Revbio, Inc.
Lowell, MA
- UEI
- ZBTLVWJKASA8
- CAGE
- 7AXM8
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 600 Suffolk St Suite 250, Lowell, MA 01854, USA
- Website
- revbio.com
- Founded
- 2014
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 59 Miscellaneous Retail
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Regents Of The University Of Michigan | U24DE029462 | $375,777 | |
| Regents Of The University Of Michigan | U24DE029462 | $224,294 | |
| Regents Of The University Of Michigan | U24DE029462 | $1,952,734 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Biovinc, LLC | Pasadena, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| WNT Scientific LLC | Rochester, NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Amend Surgical, Inc. | Alachua, FL | — |
| Rytek Medical Inc. | Lebanon, NH | — |
| Insoma Bio, Inc. | Durham, NC | — |
About the company
Revbio, Inc. is a for-profit corporate entity located in Lowell, Massachusetts, specializing in the development of advanced bone adhesive biomaterials and regenerative medical technologies. The company focuses on creating innovative solutions for orthopedic and medical applications, with a particular emphasis on addressing age-related medical challenges. Its primary product is Tetranite (TN), a novel mineral-organic bone adhesive designed to improve surgical interventions and bone healing processes across various medical domains.
Through federal grant awards, Revbio, Inc. has secured multiple project grants from agencies like the National Institute on Aging (NIA), National Institute of Neurological Disorders and Stroke, and National Institute of Dental and Craniofacial Research. These grants have supported research and development of Tetranite for diverse medical applications, including vertebral compression fracture treatments, cranial flap fixation, extremity fracture healing, and dental ridge augmentation. The company has received substantial funding, with grants ranging from approximately $500,000 to over $2 million, focusing on developing minimally invasive, image-guided delivery methods for their bone adhesive technology. Notably, Revbio has also engaged in a sub-grant award with the Regents of the University of Michigan, collaborating to optimize their injectable, cohesive organic-mineral bone graft biomaterial. The grants consistently demonstrate the company's commitment to creating safer, more effective medical solutions that address significant challenges in orthopedic and surgical treatments, particularly for aging populations.
Quick answers
Is Revbio, Inc. registered in SAM.gov?
Yes. Revbio, Inc.'s SAM.gov registration is active through June 24, 2027.
What is Revbio, Inc.'s most recent federal award?
Revbio, Inc.'s most recent federal grant award is Improved treatment options for vertebral compression fractures in elderly patients using minimally invasive… (R44AG097243), from National Institute on Aging (NIH), on September 30, 2025.
On GovTribe
See Revbio, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors